EirGenix, Inc.
Thomas Schulze is the Founder & CEO of FundaMental Pharma, a start-up focused on developing neuroprotective small molecules. With a background in biopharmaceuticals and molecular genetics, Schulze has held various leadership roles in companies such as EirGenix, Navibion, and Avontec GmbH. Thomas also has experience in gene therapy, autoimmune research, and virology. Schulze holds a Ph.D. in HIV replication and retrovirology from the Max Planck Institute for Molecular Genetics.
This person is not in any offices
EirGenix, Inc.
2 followers
EirGenix is a contract development and manufacturing organization that provides high-quality and cost-effective service. We support our clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix also specializes in the development of biologics, specializing in the development of biosimilars. Our Services: - Cell Line Development (mammalian/microbial systems) - Process Development and Process Optimization - Analytical Services and Quality Control - cGMP Manufacturing (mammalian/microbial systems) - Taiwan FDA inspected/approved - Japan PMDA inspected/approved - U.S. FDA inspection pending (June 2022) - EMA inspection pending (2022-2023) - Antibody-Drug Conjugate (ADC) Development and Manufacturing